| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Dec―29 |
Monoclonal Antibodies 4B11 and 6D7 Against SARS-CoV-2 Nucleocapsid Protein |
|
| 2 |
[GO] |
2023―Feb―14 |
COVID-19 Monoclonal Antibody Administration Linked to Drop in Blood Pressure: A Retrospective Cohort Study |
Sheena CarlLee, Alexandra Diaz-Cruz, Robert Brand, Sharon Reece, Samantha Robinson, Jack West, et al. (+2) Ryan K. Dare, Hanna Jensen |
| 3 |
[GO] |
2023―Feb―09 |
Casivirimab/Imdevimab Effect on COVID-19 Outcome and Reinfection in a Real-World SARS-COV-2 Variant Transition Period Setting |
Evanthia Tzitzi, Athina Pyrpasopoulou, Panagiotis Kalmoukos, Aristeidis Kefas, Zacharenia Kyrana, Panagiotis Doukelis, et al. (+3) Anna Varouktsi, Kostas Imprialos, Michail Doumas |
| 4 |
[GO] |
2022―Dec―28 |
Can Endemic Human Coronaviruses Be a COVID-19 Vaccine Approach? |
Thomas Kieber-Emmons |
| 5 |
[GO] |
2022―Aug―26 |
Living with Endemic COVID-19 |
Thomas Kieber-Emmons, Anastas Pashov |
| 6 |
[GO] |
2022―Aug―26 |
Establishment of Neutralizing Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 by the Screening with Exosomes Expressing the Viral Spike Protein |
Chihiro Okada, Etsuko Ikeda-Ishizaka, Chikako Ono, Yoshiharu Matsuura, Hikaru Sonoda |
| 7 |
[GO] |
2022―Aug―03 |
Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting |
Alex Belote, Sharon Reece, Samantha Robinson, Hanna Jensen, Sheena CarlLee, Megan Clark, et al. (+3) Spencer Parnell, Caroline Geels, James Newton |
| 8 |
[GO] |
2022―Apr―26 |
The Case for Acquired Immunity as a Strategy to Thwart SARS-CoV-2 Virus Infection |
Thomas Kieber-Emmons |
| 9 |
[GO] |
2021―Dec―27 |
Cancer Patients and COVID-19 Vaccination |
Thomas Kieber-Emmons |
| 10 |
[GO] |
2021―Oct―22 |
Simultaneous Detection of SARS-CoV-2 IgG/IgM Antibodies, Using Gold Nanoparticles-Based Lateral Flow Immunoassay |
Anita Ahmadi, Zahra Mirzaeizadeh, Kobra Omidfar |
| 11 |
[GO] |
2021―Apr―26 |
Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond |
Deepak Kumar, Sulgey Gauthami, Jagadeesh Bayry, Srinivas V. Kaveri, Nagendra R. Hegde |
| 12 |
[GO] |
2021―Jan―29 |
How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model |
Heinz Kohler, Srini Kaveri |
| 13 |
[GO] |
2020―Nov―02 |
A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates |
Sumeet Patiyal, Dilraj Kaur, Harpreet Kaur, Neelam Sharma, Anjali Dhall, Sukriti Sahai, et al. (+4) Piyush Agrawal, Lubna Maryam, Chakit Arora, Gajendra P.S. Raghava |
| 14 |
[GO] |
2020―Sep―30 |
The Need for a Global Network to Cope with Pandemics from Studies of the COVID Infection |
Thomas Kieber-Emmons |
| 15 |
[GO] |
2020―Aug―07 |
A Novel Hypothesis for Original Antigenic Sin in the Severe Disease of SARS-CoV-2 Infection |
Heinz Kohler, Peter Nara |
